scispace - formally typeset
W

William A. Blattner

Researcher at University of Maryland, Baltimore

Publications -  345
Citations -  26953

William A. Blattner is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Population & Virus. The author has an hindex of 80, co-authored 345 publications receiving 26023 citations. Previous affiliations of William A. Blattner include RTI International & Boston University.

Papers
More filters
Journal ArticleDOI

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

TL;DR: A mathematical model of random viral evolution and phylogenetic tree construction is developed and used to analyze 3,449 complete env sequences derived by single genome amplification from 102 subjects with acute HIV-1 (clade B) infection, suggesting a finite window of potential vulnerability of HIV- 1 to vaccine-elicited immune responses, although phenotypic properties of transmitted Envs pose a formidable defense.
Journal Article

A cancer family syndrome in twenty-four kindreds.

TL;DR: The diversity of tumor types in this syndrome suggests pathogenetic mechanisms which differ from hereditary cancers arising in single organs or tissues and laboratory markers are needed to identify high-risk individuals and families and to provide insights into susceptibility mechanisms that may be shared by a wide variety of cancers.
Journal ArticleDOI

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

TL;DR: The p53 gene in a family affected by Li–Fraumeni syndrome, a rare autosomal dominant syndrome characterized by the occurrence of diverse mesenchymal and epithelial neoplasms at multiple sites, had the same point mutation in codon 245 (GGC→GAC), which leads to substitution of aspartic acid for glycine in one of the regions identified as a frequent target of point mutations in p53.
Journal ArticleDOI

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

TL;DR: Levels of HIV-1 RNA at delivery and prenatal antiretroviral therapy were independently associated with transmission and the protective effect of therapy increased with the complexity and duration of the regimen.